Related by context. Frequent words. (Click for all words.) 61 AEterna Zentaris Inc. 61 Acadia Pharmaceuticals 60 Ardea Biosciences 59 Idenix Pharmaceuticals 59 YM BioSciences Inc. 58 ISTA Pharmaceuticals 58 Avanir Pharmaceuticals 58 WCRX 58 Transition Therapeutics Inc. 57 Celgene CELG 57 SGX Pharmaceuticals 57 ImmunoGen Inc. 56 ONXX 56 Alexza Pharmaceuticals Inc. 56 Keryx Biopharmaceuticals 56 Cortex Pharmaceuticals 56 Gilead Sciences Inc 56 Dynavax Technologies Corporation 56 Peregrine Pharmaceuticals 56 Momenta Pharmaceuticals 55 Rexahn Pharmaceuticals 55 Genetech 55 Axcan Pharma Inc. 55 PHARMACEUTICALS 55 Lorus Therapeutics Inc. 55 Halozyme Therapeutics 55 Shire Plc 55 Theratechnologies TSX TH 54 Sangamo BioSciences 54 VRTX 54 Angiotech Pharmaceuticals Inc. 54 Enzo Biochem 54 NPS Pharmaceuticals Inc. 54 Cadence Pharmaceuticals Inc. 54 Coley Pharmaceutical Group 54 AMAG Pharmaceuticals 54 Poniard Pharmaceuticals 54 Biogen Idec BIIB 54 Chelsea Therapeutics 54 Immunogen 54 Genzyme GENZ 54 Sunesis Pharmaceuticals Inc. 54 Sciele Pharma Inc. 54 Somaxon Pharmaceuticals Inc. 54 Nuvo Research 54 Aeterna Zentaris 53 Amgen NASDAQ AMGN 53 Idenix Pharmaceuticals Inc. 53 Tekmira Pharmaceuticals Corporation 53 THE TREND CONTINUES DOWN 53 Halozyme Therapeutics Inc. 53 NPS Pharmaceuticals 53 THE TREND CONTINUES LOWER 53 NASDAQ CRXL 53 Cardiome Pharma Corp. 52 Enzon Pharmaceuticals Inc. 52 DOWNTREND SPOTTED IN SHARES 52 Hana Biosciences 52 OFFERS INVESTORS BETTER VALUE 52 Vanda Pharmaceuticals Inc. 52 Angiotech Pharmaceuticals 52 AVEO Pharmaceuticals Inc. 52 Biogen Idec NASDAQ BIIB 52 Ore Pharmaceuticals 52 AMAG Pharmaceuticals Inc. 52 PharmaNet Development Group 52 Valeant Pharmaceuticals International 51 Kosan Biosciences 51 Cypress Bioscience Inc. 51 Schering Plough SGP 51 Savient Pharmaceuticals 51 % SELL OFF 51 PDLI 51 Momenta Pharmaceuticals Inc. 51 CROSSES PIVOT POINT SUPPORT 51 WEEK HIGH RECENTLY ECLIPSED 51 THE TREND CONTINUES UP 51 SHARES COULD POTENTIALLY PULLBACK 51 NEXT RESISTANCE LEVEL FOR 51 Par Pharmaceutical Companies 50 Critical Outcome Technologies 50 Natus Medical 50 Durect 50 Osiris Therapeutics 50 APPROACHES NEW UPSIDE TARGET 50 OUT IN SHARES 50 THE TREND CONTINUES HIGHER 50 Synta Pharmaceuticals 50 Molecular Insight Pharmaceuticals 50 Auxilium Pharmaceuticals 50 Novartis NVS 50 Biomira 50 Allos Therapeutics 50 Onyx Pharmaceuticals 50 Incyte Corporation 50 Paladin Labs Inc. 50 QLT 50 OccuLogix 49 Titan Pharmaceuticals 49 Cougar Biotechnology 49 RXi Pharmaceuticals